“Alzheimer’s drug spurs hope”

“Alzheimer’s drug spurs hope” is the headline in today’s (6-1-15) SF Chronicle. Biogen announced a new antibody that substantially reduced abnormal protein deposits in the brain. Patients who received the therapy had significantly less cognitive decline than the control group showed. Although this clinical trial was small, a larger one is planned for July. One […]